Gloria Dalla Costa

Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres.

Dalla Costa G, Leocani L, Pisa M, Croese T, Martinelli V, Moiola L, Sangalli F, Colombo B, Haghikia A, Gold R, Furlan R, Comi G.

Mult Scler. 2024 Oct. 30(11-12):1561-1565. PMID: 38877721

A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.

Dalla Costa G, Nos C, Zabalza A, Buron M, Magyari M, Sellebjerg F, Guerrero AI, Roselli L, La Porta ML, Martinis M, Bailon R, Kontaxis S, Laporta E, Garcia E, Pokorny FB, Schuller BW, Folarin A, Stewart C, Leocani L, Vairavan S, Cummins N, Dobson R, Hotopf M, Narayan V, Montalban X, Sorensen PS, Comi G.

Mult Scler. 2024 Jan. 30(1):103-112. PMID: 38084497

Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis.

Huang SC, Pisa M, Guerrieri S, Dalla Costa G, Comi G, Leocani L.

Brain Commun. 2024. 6(1):fcad249. PMID: 38328398

Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis.

Siddi S, Giné-Vázquez I, Bailon R, Matcham F, Lamers F, Kontaxis S, Laporta E, Garcia E, Arranz B, Dalla Costa G, Guerrero AI, Zabalza A, Buron MD, Comi G, Leocani L, Annas P, Hotopf M, Penninx BWJH, Magyari M, Sørensen PS, Montalban X, Lavelle G, Ivan A, Oetzmann C, White KM, Difrancesco S, Locatelli P, Mohr DC, Aguiló J, Narayan V, Folarin A, Dobson RJB, Dineley J, Leightley D, Cummins N, Vairavan S, Ranjan Y, Rashid Z, Rintala A, Girolamo G, Preti A, Simblett S, Wykes T, Myin-Germeys I, Haro JM.

J Clin Med. 2022 Dec 01. 11(23). PMID: 36498739

The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions.

Sun S, Folarin AA, Zhang Y, Cummins N, Liu S, Stewart C, Ranjan Y, Rashid Z, Conde P, Laiou P, Sankesara H, Dalla Costa G, Leocani L, Sørensen PS, Magyari M, Guerrero AI, Zabalza A, Vairavan S, Bailon R, Simblett S, Myin-Germeys I, Rintala A, Wykes T, Narayan VA, Hotopf M, Comi G, Dobson RJ.

Comput Methods Programs Biomed. 2022 Dec. 227:107204. PMID: 36371974

Emerging trends in multiple sclerosis research.

Dalla Costa G, Comi G.

Mult Scler Relat Disord. 2022 Dec. 68:104124. PMID: 36063731

Visual Evoked Potentials to Monitor Myelin Cuprizone-Induced Functional Changes.

Marenna S, Huang SC, Dalla Costa G, d'Isa R, Castoldi V, Rossi E, Comi G, Leocani L.

Front Neurosci. 2022. 16:820155. PMID: 35495042

Intensive Neurorehabilitation and Gait Improvement in Progressive Multiple Sclerosis: Clinical, Kinematic and Electromyographic Analysis.

Huang SC, Guerrieri S, Dalla Costa G, Pisa M, Leccabue G, Gregoris L, Comi G, Leocani L.

Brain Sci. 2022 Feb 12. 12(2). PMID: 35204021

The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.

Geys L, Parciak T, Pirmani A, McBurney R, Schmidt H, Malbaša T, Ziemssen T, Bergmann A, Rojas JI, Cristiano E, García-Merino JA, Fernández Ó, Kuhle J, Gobbi C, Delmas A, Simpson-Yap S, Nag N, Yamout B, Steinemann N, Seeldrayers P, Dubois B, van der Mei I, Stahmann A, Drulovic J, Pekmezovic T, Brola W, Tintore M, Kalkers N, Ivanov R, Zakaria M, Naseer MA, Van Hecke W, Grigoriadis N, Boziki M, Carra A, Pawlak MA, Dobson R, Hellwig K, Gallagher A, Leocani L, Dalla Costa G, de Carvalho Sousa NA, Van Wijmeersch B, Peeters LM.

Int J MS Care. 2021 Nov-Dec. 23(6):261-268. PMID: 35035297

Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.

Filippi M, Preziosa P, Meani A, Dalla Costa G, Mesaros S, Drulovic J, Ivanovic J, Rovira A, Tintorè M, Montalban X, Ciccarelli O, Brownlee W, Miszkiel K, Enzinger C, Khalil M, Barkhof F, Strijbis EMM, Frederiksen JL, Cramer SP, Fainardi E, Amato MP, Gasperini C, Ruggieri S, Martinelli V, Comi G, Rocca MA.

Neurology. 2022 01 04. 98(1):e1-e14. PMID: 34716250